These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31049833)

  • 21. Effects of Hedan Tablet () on lipid profile, proprotein convertase subtilisin/kexin type 9 and high-density lipoprotein subfractions in patients with hyperlipidemia: A primary study.
    Xu RX; Wu NQ; Li S; Zhang Y; Li XL; Guo YL; Zhu CG; Liu G; Dong Q; Li JJ
    Chin J Integr Med; 2016 Sep; 22(9):660-5. PubMed ID: 25967607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of evolocumab alone and in combination with atorvastatin on atherosclerosis progression and TLRs expression.
    Saud A; Ali N; Gali F; Qassam H; Hadi NR
    J Med Life; 2023 May; 16(5):759-765. PubMed ID: 37520489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 10-DHGD ameliorates cisplatin-induced nephrotoxicity in rats.
    Elseweidy MM; Zaghloul MS; Younis NN
    Biomed Pharmacother; 2016 Oct; 83():241-246. PubMed ID: 27376779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aqueous extract of Gleditsia sinensis Lam. fruits improves serum and liver lipid profiles and attenuates atherosclerosis in rabbits fed a high-fat diet.
    Lai P; Du JR; Zhang MX; Kuang X; Li YJ; Chen YS; He Y
    J Ethnopharmacol; 2011 Oct; 137(3):1061-6. PubMed ID: 21718773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of pro-protein convertase subtilisin kexin 9 [corrected] (PCSK-9) as a treatment for hyperlipidaemia.
    Wierzbicki AS; Hardman TC; Viljoen A
    Expert Opin Investig Drugs; 2012 May; 21(5):667-76. PubMed ID: 22493980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.
    Hirano T; Yamashita S; Takahashi M; Hashimoto H; Mori Y; Goto M
    Metabolism; 2016 Jun; 65(6):893-903. PubMed ID: 27173468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperlipidemia: Management with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors.
    Shahreyar M; Salem SA; Nayyar M; George LK; Garg N; Koshy SKG
    J Am Board Fam Med; 2018; 31(4):628-634. PubMed ID: 29986989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antiatherogenic effect of bixin in hypercholesterolemic rabbits is associated to the improvement of lipid profile and to its antioxidant and anti-inflammatory effects.
    Somacal S; Figueiredo CG; Quatrin A; Ruviaro AR; Conte L; Augusti PR; Roehrs M; Denardin IT; Kasten J; da Veiga ML; Duarte MM; Emanuelli T
    Mol Cell Biochem; 2015 May; 403(1-2):243-53. PubMed ID: 25702177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypercholesterolemia and aortic glycosaminoglycans of rabbits fed semi-purified diets containing sucrose and lactose.
    Sparks JD; Sparks CE; Kritchevsky D
    Atherosclerosis; 1986 May; 60(2):183-96. PubMed ID: 3521623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy.
    Smith L; Mosley J; Yates J; Caswell L
    J Pharm Pharm Sci; 2016; 19(1):137-46. PubMed ID: 27096698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proprotein convertase subtilisin/kexin type 9 and mortality in patients starting hemodialysis.
    Strålberg T; Nordenskjöld A; Cao Y; Kublickiene K; Nilsson E
    Eur J Clin Invest; 2019 Jul; 49(7):e13113. PubMed ID: 30921469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders.
    Gupta S
    Vasc Health Risk Manag; 2016; 12():421-433. PubMed ID: 27877050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fenofibrate reduces tumor necrosis factor-alpha serum concentration and adipocyte secretion of hypercholesterolemic rabbits.
    Zhao SP; Wu J
    Clin Chim Acta; 2004 Sep; 347(1-2):145-50. PubMed ID: 15313152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What role will proprotein convertase subtilisin/kexin type 9 inhibitors play in hyperlipidemia management?
    Stein EA
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):97-105. PubMed ID: 26859553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of artesunate and ursolic acid on hyperlipidemia and its complications in rabbit.
    Wang YL; Wang ZJ; Shen HL; Yin M; Tang KX
    Eur J Pharm Sci; 2013 Nov; 50(3-4):366-71. PubMed ID: 23954455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypolipidemic effects of HVC1 in a high cholesterol diet‑induced rat model of hyperlipidemia.
    Kim CY; Chung KS; Cheon SY; Lee K; Ham I; Choi HY; Cho YB; Cho BH; Mok SY; An HJ
    Mol Med Rep; 2016 Oct; 14(4):3152-8. PubMed ID: 27510839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin attenuates adhesion molecules and matrix metalloproteinase expression in hypercholesterolemic rabbits.
    Um MY; Hwang KH; Choi WH; Ahn J; Jung CH; Ha TY
    Nutr Res; 2014 Oct; 34(10):886-93. PubMed ID: 25282128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pravastatin decreases serum lipids and vascular cholesterol deposition in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Khachadurian AK; Shimamura T; Rozovski SJ; Ananthakrishnan R; Armenian B; Coly E; alHinai A; Martucci C; Schneider SH; Amorosa LF
    Jpn Heart J; 1991 Sep; 32(5):675-85. PubMed ID: 1774829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.